~~<i id='83632812BF'><strike id='83632812BF'><tt id='83632812BF'><pre id='83632812BF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：focus 2025-09-14 10:07:01 - browse：58

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Nearly two

hotspot

leisure time

Wikipedia

focus

explore

focus

AdobeThisarticleispartofapartnershipbetweenFirstOpinionandTradeoffs, apodcastexploringourconfusing,c

WSS

Peter Marks talks Operation Warp Speed for Rare Diseases

'Ancient DNA,' 23andMe reveal African American ancestries

A revolution in caring for preterm infants

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Attacks on the drug industry will lead to fewer breakthroughs

European regulators consider appeal over Amylyx ALS drug

focus

entertainment

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

What the cancer research community can learn from the Covid response

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Peter Marks talks Operation Warp Speed for Rare Diseases

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stem cell clinics for heart failure: buyer be wary

Medical records are filled with copy

Readout LOUD podcast: Merger Mondays, Ozempic panic

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

A revolution in caring for preterm infants

leisure time

Bernie Sanders bashes nonprofit hospitals over their tax breaks

A fraught question for the kids of Alzheimer’s: Is it coming for us?

TytoCare raises $49 million to build out AI

European regulators consider appeal over Amylyx ALS drug

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Humana, CVS hope to turn members into patients at clinics

Wikipedia

focus

explore

focus